Filing Details
- Accession Number:
- 0001104659-20-066481
- Form Type:
- 4
- Zero Holdings:
- No
- Publication Time:
- 2020-05-27 17:02:02
- Reporting Period:
- 2020-05-22
- Accepted Time:
- 2020-05-27 17:02:02
- SEC Url:
- Form 4 Filing
Issuer
Cik | Name | Symbol | Sector (SIC) | IRS No |
---|---|---|---|---|
1297184 | Amphastar Pharmaceuticals Inc. | AMPH | Pharmaceutical Preparations (2834) | 330702205 |
Insiders
Cik | Name | Reported Address | Insider Title | Director | Officer | Large Shareholder | Other |
---|---|---|---|---|---|---|---|
1379941 | Howard Lee | C/O Amphastar Pharmaceuticals, Inc. 11570 6Th Street Rancho Cucamonga CA 91730 | Yes | No | No | No |
Reported Non-Derivative Transactions
Sec. Name | Acquisiton - Disposition | Date | Amount | Price | Remaning Holdings | Equity Swap Involved | Form Type | Code | Nature of Ownership | Explanation |
---|---|---|---|---|---|---|---|---|---|---|
Common Stock | Acquisiton | 2020-05-22 | 10,000 | $15.11 | 138,081 | No | 4 | M | Direct | |
Common Stock | Disposition | 2020-05-22 | 10,000 | $18.36 | 128,081 | No | 4 | S | Direct | |
Common Stock | Acquisiton | 2020-05-26 | 10,000 | $15.11 | 138,081 | No | 4 | M | Direct | |
Common Stock | Disposition | 2020-05-26 | 10,000 | $18.60 | 128,081 | No | 4 | S | Direct |
Equity Swap Involved | Form Type | Code | Nature of Ownership | Explanation |
---|---|---|---|---|
No | 4 | M | Direct | |
No | 4 | S | Direct | |
No | 4 | M | Direct | |
No | 4 | S | Direct |
Reported Derivative Transactions
Sec. Name | Sec. Type | Acquisiton - Disposition | Date | Amount | Price | Amount - 2 | Price - 2 |
---|---|---|---|---|---|---|---|
Common Stock | Stock Option (right to buy) | Disposition | 2020-05-22 | 10,000 | $0.00 | 10,000 | $15.11 |
Common Stock | Stock Option (right to buy) | Disposition | 2020-05-26 | 10,000 | $0.00 | 10,000 | $15.11 |
Remaning Holdings | Exercise Date | Expiration Date | Equity Swap Involved | Transaction Form Type | Transaction Code | Nature of Ownership |
---|---|---|---|---|---|---|
10,000 | 2020-05-27 | No | 4 | M | Direct | |
0 | 2020-05-27 | No | 4 | M | Direct |
Footnotes
- The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $18.05 to $18.59 shares sold at each separate price within the ranges set forth in footnotes (1) and (2) to this Form 4.
- The price reported in Column 4 is weighted average price. These shares were sold in multiple transactions at prices ranging from $18.42 to $18.94, inclusive.
- Shares subject to the option are fully vested and immediately exercisable.